22.3.2011
•
News
KSB nominated for Chambers Europe Awards for Excellence 2011
Kocián Šolc Balaštík is one of five Czech law firms nominated for this year’s Chambers Europe Awards for Excellence in the category of National Firms. KSB won the award in 2008 and was shortlisted as one of the best law firms in 2009 and 2010.
The Chambers Europe Awards for Excellence are awarded by Chambers and Partners, a reputable British rating company that has rated legal firms and services worldwide since 1990. The Europe Awards started to include Czech jurisdiction in 2008 and KSB was the first law firm ever to receive the National Firm Award in the Czech Republic.
For more details on this year’s Chambers Europe Awards for Excellence nominations, please click here
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
